EmitBio has been awarded a patent for its biotechnology therapy to treat respiratory pathogens, like SARS-CoV-2 and its variants, including Delta, and a peer-reviewed manuscript describing the process and application of light therapy was published in Scientific Reports.
Source: WRAL News
Durham-based biotech company granted US patent for the use of light to limit, eliminate virus that causes COVID-19
Published in News
More from NewsMore posts in News »
- Children spent hours inside cold car in Rocky Mount with 2 bodies inside
- Woman shot on New Bern Ave., transported to WakeMed
- Durham kicks off new downtown social district "The Bullpen"
- Rules changing for NC Christmas parades after child killed in Raleigh
- Pineville Police reforming several policies after woman jumps out of patrol car
Be First to Comment